News

AddToAny

Google+ Facebook Twitter Twitter

IBMS podcast relaunched

The IBMS Biopod has been revamped, renamed and relaunched as IBMSpod.

It is a monthly podcast for members and each episode features an interview with a top scientist discussing research and talking about the latest developments. 

The IBMSpod also features new segments, including a round-up of IBMS news, an interview with a member called Lab Life and the chance for members to put their questions to the main interviewee via social media. The guest on the first episode, which can be streamed now, is Guy Orchard, recent winner of the AHA Biomedical Scientist of the Year award. 

The podcasts are a CPD resource for members. ibms.org/resources

Image Credit | iStock

Related Articles

melanoma cell - CREDIT - science-photolibrary-f0403499

Phenotypic plasticity in melanoma: the impact on management strategies

Dr Ghada Elayat looks at the role of epithelial–mesenchymal transition in cancer and the implications for melanoma development.

A.I., Chat with AI, Artificial Intelligence-CREDIT-iStock-1494073860

AI search engines put to the test

Four proposed state-of-the-art image search engines for automating search and retrieval of digital histopathology slides were found to be of inadequate performance for routine clinical care, US research suggests.

alexandra grainey and team CREDIT_Supplied

My lab: innovative cellular pathology

A guided tour of cellular pathology at One Dorset Pathology.

big question headline

What safeguards and regulations would you like to see in place for AI pathology?

With artificial intelligence (AI) becoming ever more sophisticated and prevalent across society, combined with advances in digital pathology and the fast-paced progress in deep learning, we may be on the cusp of the era of AI in pathology. However, with technical, logistical and ethical barriers in place, we look at what measures are needed before widespread clinical adoption.

Top